Modalis Therapeutics News, Researches, Clinical Trials and Articles

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Press Releases September 11, 2026 0

Exegenesis Bio and Modalis Therapeutics Corporation have announced a...

Research September 10, 2026 0

Tevard’s suppressor tRNA therapy could offer a new way...

Press Releases September 9, 2026 0

Satellos Bioscience has announced that its investigational Duchenne muscular...

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

Modalis Therapeutics